https://www.zora.uzh.ch/id/eprint/150846/1/ehx391.pdf

2017 ESC/EACTS Guidelines for the management of valvular heart disease

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography : An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

http://www.jse.gr.jp/2016_LVDiastolicFunction.pdf

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

https://www.healthcare.uiowa.edu/familymedicine/fpinfo/Docs/Chest%20Rx%20VTE%20Feb%202016.pdf

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report

During the past decade, catheter ablation of atrial fibrillation (AF) has evolved rapidly from an investigational procedure to its current status as a commonly performed ablation procedure in many major hospitals throughout the world. Surgical ablation of AF, using either standard or minimally invasive techniques, is also performed in many major hospitals throughout the world.

In 2007, an initial Consensus Statement on Catheter and Surgical AF Ablation was developed as a joint effort of the Heart Rhythm Society, the European Heart Rhythm Association, and the European Cardiac Arrhythmia Society.1 The 2007 document was also developed in collaboration with the Society of Thoracic Surgeons and the American College of Cardiology. Since the publication of the 2007 document, there has been much learned about AF ablation, and the indications for these procedures have changed. Therefore the purpose of this 2012 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AF and to report the findings of a Task Force, convened by the Heart Rhythm Society, the European Heart Rhythm Association, and the European Cardiac Arrhythmia Society and charged with defining the indications, techniques, and outcomes of this procedure. Included within this document are recommendations pertinent to the design of clinical trials in the field of AF ablation, including definitions relevant to this topic.

This statement summarizes the opinion of the Task Force members based on an extensive literature review as well as their own experience. It is directed to all health care professionals who are involved in the care of patients with AF, particularly those who are undergoing, or are being considered for, catheter or surgical ablation procedures for AF. This statement is not intended to recommend or promote catheter ablation of AF. Rather the ultimate judgment regarding care of a particular patient …

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

Echocardiographic assessment of left ventricular (LV) diastolic function is an integral part of the routine evaluation of patients presenting with symptoms of dyspnea or heart failure. The 2009 American Society of Echocardiography (ASE) and European Association of Echocardiography (now European Association of Cardiovascular Imaging [EACVI]) guidelines for diastolic function assessment were comprehensive, including several two-dimensional (2D) and Doppler parameters to grade diastolic dysfunction and to estimate LV filling pressures.1 Notwithstanding, the inclusion of many parameters in the guidelines was perceived to render diastolic function assessment too complex, because several readers have interpreted the guidelines as mandating all the listed parameters in the document to fall within specified values before assigning a specific grade. The primary goal of this update is to simplify the approach and thus increase the utility of the guidelines in daily clinical practice.

LV diastolic dysfunction is usually the result of impaired LV relaxation with or without …

We present an exceptional case of a quadricuspid aortic valve associated with a left atrial myxoma. Both are rare conditions, and this association has not been reported yet. These conditio...

An Exceedingly Rare Case of Concomitant Quadricuspid Aortic Valve and Atrial Myxoma.

Summary Background. — Elderly patients with an acute coronary syndrome (ACS) are less likely to be enrolled into randomized, controlled trials or receive guideline-recommended therapies, because of a higher burden of comorbidity, including functional decline. Aim. — To assess the prognostic value of functional decline in a prospective, observational cohort of elderly ACS patients. Methods. — ACS patients aged ≥ 70 years were enrolled. The ACS definition included STand non-ST-segment elevation myocardial infarction, and unstable angina pectoris. Clinical admission and laboratory data and echocardiographic variables were recorded. Functional

Functional decline in elderly patients presenting with acute coronary syndromes: Impact on midterm outcome Impact pronostique à moyen terme de la perte d'autonomie chez les sujets âgés hospitalisés pour un syndrome coronaire aigu

Letter relating to the publication entitled "Evolution of acute coronary syndrome with normal coronary arteries and normal cardiac magnetic resonance imaging" by Chopard et al. (Arch Cardiovasc Dis 2011;104:509-17).

The novel Coronavirus (2019-nCoV) first detected in Wuhan, China, is currently causing concern in the medical community as the virus is spreading and threatening the world including the Western cou...

Pierre-Vladimir Ennezat

Papers

An Exceedingly Rare Case of Concomitant Quadricuspid Aortic Valve and Atrial Myxoma.

Functional decline in elderly patients presenting with acute coronary syndromes: Impact on midterm outcome Impact pronostique à moyen terme de la perte d'autonomie chez les sujets âgés hospitalisés pour un syndrome coronaire aigu

Letter relating to the publication entitled "Evolution of acute coronary syndrome with normal coronary arteries and normal cardiac magnetic resonance imaging" by Chopard et al. (Arch Cardiovasc Dis 2011;104:509-17).

Fighting non-communicable diseases in the COVID-19 era: a catch 22?

Real Clinical Significance of Statin Cessation After Adjustment for Smoking Persistence and Antiplatelet Treatment Discontinuation